Drugplain

STEGLATRO 5 mg/1

ertugliflozin · TABLET, FILM COATED · Merck Sharp & Dohme LLC

No Recall History
Plain English

Steglatro (ertugliflozin) is an oral tablet used to help lower blood sugar levels in patients with type 2 diabetes. It works by helping your kidneys remove excess sugar through your urine.

Key Facts

Brand Name
STEGLATRO
Generic Name
ertugliflozin
NDC Code (Product)
0006-5363
Manufacturer
Merck Sharp & Dohme LLC
Strength
5 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA209803
Marketing Start
12/19/2017

Recall History

No Recall History

Frequently Asked Questions

What is STEGLATRO used for?

Steglatro (ertugliflozin) is an oral tablet used to help lower blood sugar levels in patients with type 2 diabetes. It works by helping your kidneys remove excess sugar through your urine.

Is STEGLATRO a controlled substance?

STEGLATRO is not classified as a controlled substance by the DEA.

What is the generic name for STEGLATRO?

The generic name for STEGLATRO is ertugliflozin. There are 6 other brand versions of ertugliflozin.

What is the NDC code for STEGLATRO 5 mg/1?

The NDC (National Drug Code) for STEGLATRO 5 mg/1 is 0006-5363, listed by Merck Sharp & Dohme LLC.

Product NDC

0006-5363

Package NDC

0006-5363-03

Other STEGLATRO Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)